Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. Y. van Sleen

Publicaties

Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis

GM-CSF drives IL-6 production by macrophages in polymyalgia rheumatica

Altered plasma levels and tissue expression of fibroblast activation protein alpha in giant cell arteritis

Clonal hematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls

Effects of ageing and frailty on circulating monocyte and dendritic cell subsets

Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster

Impaired IL-6-induced JAK-STAT signaling in CD4+ T cells associates with longer treatment duration in giant cell arteritis

mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy

Multiple vaccine comparison in the same adults reveals vaccine-specific and age-related humoral response patterns: an open phase IV trial

Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

Pers/media

How Does COVID-19 Booster Affect Patients With GCA and Low Primary Vaccine Response?

Biomarkers may improve giant cell arteritis diagnosis

Vasculitis Foundation: international research insights